慢性高血压孕妇早孕期早产型子痫前期的预测与预防
基于两项多中心早孕期子痫前期筛查研究(共51024例单胎妊娠,其中慢性高血压556例)的分析显示,慢性高血压孕妇中58例(10.4%)发生早产型子痫前期。贝叶斯分析表明阿司匹林可将因早产型子痫前期导致的分娩平均延迟3.6周(95%可信区间0.2-6.6),产后获益概率98%。FMF竞争风险模型判别能力良好(AUC 0.819,95%CI 0.763-0.874),校准充分,净获益高于全部治疗策略;预测风险主要受MAP和PlGF影响,UtA-PI贡献较小。
要点
- 慢性高血压孕妇早产型子痫前期发生率10.4%(58/556)。
- 阿司匹林使因早产型子痫前期导致的分娩平均延迟3.6周。
- FMF模型AUC 0.819,可识别低危(<1/100)和高危孕妇。
核心结论
- 在慢性高血压孕妇中,阿司匹林可延迟因早产型子痫前期导致的分娩,早孕期FMF竞争风险模型能可靠识别低危和高危个体,预测风险主要由MAP和PlGF驱动,支持早孕期风险分层和个体化管理。
研究设计与样本
- 基于两项多中心早孕期子痫前期筛查研究(联合多标志物筛查与阿司匹林随机治疗预防子痫前期循证试验和子痫前期筛查项目试验)的数据分析,共纳入51024例单胎妊娠孕妇,其中慢性高血压556例(1.1%);采用贝叶斯推断评估阿司匹林效果,通过判别能力、校准和决策曲线分析评价FMF模型筛查性能,并利用经验数据和蒙特卡洛模拟结合广义可加模型探讨产次、既往子痫前期和生物标志物对风险分类的影响。
诊断标准与关键数值
- FMF早孕期竞争风险模型对慢性高血压孕妇早产型子痫前期的判别能力AUC为0.819(95%CI 0.763-0.874),校准充分,净获益高于全部治疗策略;低危阈值定义为风险<1/100,慢性高血压孕妇中21.8%被归为低危,主要为初产妇和无既往子痫前期的经产妇。
临床应用与阅片要点
- 对慢性高血压孕妇可在早孕期采用FMF竞争风险模型进行早产型子痫前期风险分层,模型预测风险主要受MAP和PlGF影响,UtA-PI贡献较小;阿司匹林可使因早产型子痫前期导致的分娩平均延迟3.6周(95%可信区间0.2-6.6),产后获益概率98%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the effect of aspirin on gestational age at delivery due to preterm pre-eclampsia (PE) in women with chronic hypertension (CH), to assess the predictive performance of the Fetal Medicine Foundation (FMF) first-trimester competing-risks model for preterm PE in this high-risk group and to evaluate how parity, previous PE and biomarker values influence individualized risk estimates.
METHODS: We analyzed data from two multicenter first-trimester PE screening studies: the Combined Multimarker Screening and Randomized Patient Treatment with Aspirin for Evidence-based Preeclampsia Prevention trial and the Screening Program for Preeclampsia trial. The effect of aspirin on gestational age at delivery due to PE was assessed using Bayesian inference. The screening performance of the FMF model was evaluated by discrimination, calibration and decision-curve analysis. The influence of parity, previous PE and biomarkers (mean arterial pressure (MAP), uterine artery pulsatility index (UtA-PI) and placental growth factor (PlGF)) on risk classification was explored using empirical data and Monte Carlo simulations with generalized additive models.
RESULTS: The combined dataset included 51 024 women with a singleton pregnancy, of whom 556 (1.1%) had CH. Among the women with CH, 58 (10.4%) developed preterm PE. Bayesian analysis indicated that aspirin delayed delivery due to PE by a mean of 3.6 (95% credible interval, 0.2-6.6) weeks, with a 98% posterior probability of benefit. The FMF model demonstrated good discrimination (area under the receiver-operating-characteristics curve, 0.819 (95% CI, 0.763-0.874)), adequate calibration and higher net benefit compared with a treat-all approach. Overall, 21.8% of women with CH were classified as low risk (< 1 in 100) for preterm PE, consisting mostly of nulliparous women and parous women without previous PE. Predicted risks for preterm PE were strongly influenced by MAP and PlGF, with UtA-PI contributing to a lesser extent.
CONCLUSIONS: In women with CH, aspirin can delay delivery due to preterm PE, and first-trimester risk assessment using the FMF competing-risks model reliably identifies low- and high-risk individuals. The predicted risk is driven primarily by MAP and PlGF, supporting risk stratification and individualized management in early pregnancy. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Rolnik DL, Gil-Pugliese S, Syngelaki A, et al. First-trimester prediction and prevention of preterm pre-eclampsia in women with chronic hypertension. Ultrasound Obstet Gynecol. 2026. PMID: 41903191. doi:10.1002/uog.70212
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。